2型糖尿病患者对起搏器治疗的需求增加:与年龄和性别匹配的普通人群对照比较
基于瑞典国家糖尿病登记库的人群匹配注册研究,纳入416247例2型糖尿病患者和2081235例年龄性别匹配的对照,平均随访7年。2型糖尿病与起搏器治疗需求增加相关(HR 1.65,95%CI 1.60-1.69),多因素调整后仍显著(HR 1.56,95%CI 1.51-1.60)。年龄、HbA1c、BMI、糖尿病病程及降脂降压药物使用与起搏器植入风险相关。
要点
- 2型糖尿病患者起搏器植入风险较匹配对照增加65%,调整后仍增加56%。
- 年龄增长、HbA1c升高、BMI增加和糖尿病病程延长与起搏器需求相关。
- 使用降脂和降压药物也与起搏器植入风险增加相关。
核心结论
- 2型糖尿病患者对起搏器治疗的需求高于年龄和性别匹配的普通人群对照。
- 年龄、糖尿病病程和HbA1c似乎是起搏器治疗的风险因素。
研究设计与样本
- 人群匹配注册研究,纳入瑞典国家糖尿病登记库中416247例2型糖尿病患者和2081235例年龄性别匹配的普通人群对照。
- 纳入时间为1998年1月1日至2012年12月31日,随访至2013年12月31日,平均随访7年。
- 采用Cox比例风险回归分析估计起搏器治疗需求及相关因素。
主要发现
- 2型糖尿病与起搏器治疗需求增加相关(HR 1.65,95%CI 1.60-1.69;P<0.0001)。
- 调整年龄、性别、教育水平、婚姻状况、出生国家和冠心病后,风险仍显著(HR 1.56,95%CI 1.51-1.60;P<0.0001)。
- 起搏器植入风险因素包括年龄增长、HbA1c、BMI、糖尿病病程以及降脂和降压药物使用。
临床怎么用
- 对2型糖尿病患者应关注缓慢心律失常风险,尤其高龄、长病程及HbA1c控制不佳者。
- 起搏器需求增加提示需在糖尿病管理中考虑心律失常监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with type 2 diabetes have an increased risk for cardiovascular disease, including arrhythmias. The prevalence of bradyarrhythmia and the subsequent need for treatment with pacemakers (PMs) is less well explored in a contemporary patient population. The current study explores 1) whether patients with type 2 diabetes have an increased demand for PM implantation compared with an age- and sex-matched control population without diabetes and 2) patient characteristics associated with an increased demand for receiving a PM. RESEARCH DESIGN AND METHODS: In this population-matched registry study, a total of 416,247 patients with type 2 diabetes from the Swedish National Diabetes Registry and 2,081,235 age- and sex-matched control subjects selected from the general population were included between 1 January 1998 and 31 December 2012 and followed until 31 December 2013. Mean follow-up time was 7 years. Cox proportional hazards regression analyses were performed to estimate the demand of PM treatment and the factors identifying patients with such demand. RESULTS: Type 2 diabetes was associated with an increased need of PM treatment (hazard ratio 1.65 [95% CI 1.60-1.69]; P < 0.0001), which remained (1.56 [1.51-1.60]; P < 0.0001) after adjustments for age, sex, educational level, marital status, country of birth, and coronary heart disease. Risk factors for receiving a PM included increasing age, HbA1c, BMI, diabetes duration, and lipid- and blood pressure-lowering medication. CONCLUSIONS: The need for PM treatment is higher in patients with type 2 diabetes than in matched population-based control subjects. Age, diabetes duration, and HbA1c seem to be risk factors for PM treatment.
引用
- Rautio E, Gadler F, Gudbjörnsdottir S, et al. Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Diabetes Care. 2020. PMID: 32887704. doi:10.2337/dc20-0084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。